Plain-English translation of NCT07141043 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a one-year monitoring study designed to understand how kidney disease and kidney transplants affect bone health. Researchers will measure bone density, strength, and blood minerals in three groups: people on dialysis, people who have received kidney transplants, and people with osteoporosis. The goal is to see how these groups differ and whether any bone treatments help.
People with kidney disease often develop weak bones, but doctors don't have clear guidelines on how to assess and treat bone problems in transplant patients. This study aims to fill that gap by comparing bone health across different kidney disease groups to improve how these conditions are diagnosed and managed.
You likely qualify if…
You likely don't qualify if…
You will visit the study center at the beginning and again after one year. At each visit, researchers will measure your bone density using special scans, take blood samples to check calcium and phosphate levels, and review your medical history. Some participants may be receiving treatment for bone health during the study, while others may not—the researchers will monitor both groups to see what works best.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Romania
Sponsor
Grigore T. Popa University of Medicine and Pharmacy
Enrollment target
~180 participants
Started
March 2025
Primary completion
December 2026
Age range
20 Years – 70 Years
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Nada Akad, Dr.
Grigore T. Popa University of Medicine and Pharmacy
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.